2017 Imaging Abstracts

GCOS2017-P2-034

Initial results of the oncology echocardiogram program at a single Canadian tertiary care institution

Presenting Author: Dr. Christine Brezden-Masley, Staff Medical Oncologist, St. Michael’s Hospital, Toronto, ON, Canada

 

GCOS2017-P2-035

Right ventricular dysfunction in patients with anthracycline chemotherapy and left ventricular impairment

Presenting Author: Dr. Egle Ciburiene, Cardio-Oncology Fellow, Royal Brompton Hospital, London, United Kingdom

 

GCOS2017-P2-036

Late morpho-functional characteristics of anthracycline cardiomyopathy: novel insights from cardiovascular magnetic resonance at 1.5T

Presenting Author: Dr. Iwan Harries, Specialty Registrar, Bristol Heart Institute, Bristol, UK

 

GCOS2017-P2-037

Left ventricular deformation imaging in adult cancer survivors with a normal ejection fraction: An age and sex-matched case-control cardiovascular magnetic resonance study

Presenting Author: Dr. Iwan Harries, Cardiology Specialist Registrar / Research Fellow, Bristol Heart Institute, Bristol, United Kingdom

 

GCOS2017-P2-038

Potential use of quantitative cardiac MRI to detect myocardial changes in breast cancer patients undergoing tangential radiotherapy

Presenting Author: Dr. Eng-Siew Koh, Radiation Oncologist, Liverpool Hospital, Liverpool, NSW, Australia

 

GCOS2017-P2-039

Routine use of global longitudinal strain for early identification of subclinical left ventricular dysfunction among cancer patients

Presenting Author: Dr. Michal Laufer-Perl, Cardiologist, Tel Aviv Sourasky Medical Centre, Tel Aviv, Israel

 

GCOS2017-P2-040

Left ventricular regional wall motion abnormality is a strong predictor of cardiotoxicity in a prospective cohort of breast cancer patients undergoing chemotherapy

Presenting Author: Dr. Ariane Macedo, Scientific Coordinator, Mater Dei Hospital, Belo Horizonte, Brazil

 

GCOS2017-P2-041

Myocardial strain imaging by cardiac MRI for detection of subclinical myocardial dysfunction in breast cancer patients receiving trastuzumab and chemotherapy

Presenting Author: Dr. Geraldine Ong, Fellow, St. Michael’s Hospital, Toronto, ON, Canada

 

GCOS2017-P2-042

Serial changes in contractile function and myocardial inflammation in single agent versus combination chemotherapy: Findings from the Cardiotoxicity Prevention Research Initiative (CAPRI) Pilot Study

Presenting Author: Dr. Alessandro Satriano, Scientific Programmer, Stephenson Cardiac Imaging Centre, Calgary, AB, Canada

 

GCOS2017-P2-043

Analysis of cardiac sympathetic nerve activity by I-123 MIBG imaging in patients with trastuzumab-induced left ventricular dysfunction

Presenting Author: Dr. Wataru Shioyama, Associate Chief, Osaka Internaitonal Cancer Institute, Osaka, Japan

 

GCOS2017-P2-044

Evaluation of the use of inpatient cardiac magnetic resonance imaging in Cardio-Oncology

Presenting Author: Dr. Hazel Turner, Barts Health NHS Trust, London, United Kingdom

 

GCOS2017-P2-045

Right ventricular function in breast cancer patients: which echocardiographic parameters correlate best with CMR-derived ejection fraction?

Presenting Author: Dr. Lucia Venneri, Senior Clinical Fellow, Royal Brompton Hospital NHS Trust, London, United Kingdom

 

GCOS2017-P2-046

Proposed algorithm to optimize myocardial strain imaging: Improving echo lab throughput and quality in a Cardio-Oncology program

Presenting Author: Dr. Rey Vivo, Co-Director, Cardio-Oncology Program, Community Health Network, Indianapolis, Indiana, USA